Skip to main content
Equibles

Simon Fry

CDT Equity Inc. (CDT)

Board Member

CDT Equity Inc. (CDT)

Equibles does not estimate personal net worth.

Get an email with a short summary when CDT Equity Inc. publishes a filing, an earnings call transcript or a press release.

Get CDT alerts

About Simon Fry

Simon Fry is recorded as Board Member at CDT Equity Inc. (CDT) since January 1, 2024. The newest filing on record that lists Simon Fry as Board Member at CDT Equity Inc. (CDT) is dated August 11, 2026. CDT Equity Inc. reported in an 8-K filed April 27, 2026 that Simon Fry was appointed chairperson of the Audit Committee, effective April 27, 2026. CDT Equity Inc. reported in an 8-K filed November 19, 2024 that Simon Fry was appointed director, and a member of the Audit Committee and the Compensation Committee, effective December 18, 2024. CDT Equity Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CDT Equity Inc. includes Andrew Regan (CEO and Board Member), David Tapolczay (CEO and Board Member), James Bligh (CEO, CFO and Board Member) and 6 others.

“Simon Fry has been appointed as chairperson of the Audit Committee.”
CDT Equity Inc. Form 8-K, filed April 27, 2026 · Read the filing
“On November 14, 2024, upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors (the "Board") of Conduit Pharmaceuticals Inc. (the "Company") appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024, upon the conclusion of the Company's 2024 annual meeting of stockholders.”
CDT Equity Inc. Form 8-K, filed November 19, 2024 · Read the filing

Affiliation history

Company network

CDT Equity Inc.

CDT

Current role

Biotechnology · Healthcare

Board Member

2024-01-01–present

Leadership on record at CDT Equity Inc.

Recent activity